業績

2016年度 :: 著書・雑誌 :: 英文 :: 総説 :: 業績

Novel treatment of hepatitis C virus infection for patients with renal impairment.

Suda G, Ogawa K, Kimura M, Nakai M, Sho T, Morikawa K, Sakamoto N.

J Clin Transl Hepatol. 2016; 4(4): 320-327

Viral life cycle of hepatitis B virus: host factors and druggable targets.

Morikawa K, Suda G, Sakamoto N.

Hepatol Res. 2016; 46(9): 871-877

Hepatitis B: progress in understanding chronicity, immune response, and cccDNA protection.

Morikawa K, Shimazaki T, Takeda R, Izumi T, Umemura M, Sakamoto N.

Ann Transl Med. 2016; 4(18): 337

Asian consensus statements on endoscopic management of walled-off necrosis. Part 2: Endoscopic management.

Isayama H, Nakai Y, Rerknimitr R, Khor C, Lau J, Wang HP, Seo DW, Ratanachu-Ek T, Lakhtakia S, Ang TL, Ryozawa S, Hayashi T, Kawakami H, Yamamoto N, Iwashita T, Itokawa F, Kuwatani M, Kitano M, Hanada K, Kogure H, Hamada T, Ponnudurai R, Moon JH, Itoi T, Yasuda I, Irisawa A, Maetani I.

J Gastroenterol Hepatol. 2016; 31(9): 1555-1565

Asian consensus statements on endoscopic management of walled-off necrosis Part 1: Epidemiology, diagnosis, and treatment.

Isayama H, Nakai Y, Rerknimitr R, Khor C, Lau J, Wang HP, Seo DW, Ratanachu-Ek T, Lakhtakia S, Ang TL, Ryozawa S, Hayashi T, Kawakami H, Yamamoto N, Iwashita T, Itokawa F, Kuwatani M, Kitano M, Hanada K, Kogure H, Hamada T, Ponnudurai R, Moon JH, Itoi T, Yasuda I, Irisawa A, Maetani I.

J Gastroenterol Hepatol. 2016; 31(9): 1546-1554

>